Trump’s 2027 Budget Proposes $111.1 Billion Cut to HHS as Kennedy Defends Reductions Amid Vaccine and GAVI Funding Controversy

Entertainment industry stakeholders are watching closely as Health and Human Services Secretary Robert F. Kennedy Jr. Continues to defend the Trump administration’s proposed 12.5% cut to the Department of Health and Human Services budget, a reduction that could impact public health initiatives with ripple effects across media and cultural programming.

During an April 21 hearing before the Senate Appropriations Subcommittee on Labor, Health and Human Services, Kennedy faced questioning about the administration’s proposal to reduce HHS funding to $111.1 billion for fiscal year 2027, which represents a decrease from current levels. Subcommittee vice chair Tammy Baldwin of Wisconsin opened the hearing by stating she expects Congress to reject the budget request, characterizing it as reflecting priorities that favor increased military spending over domestic health programs.

Kennedy maintained that personnel within HHS do not support the proposed cuts, stating that funding decisions rest with Congress rather than agency leadership. When pressed by Senator Patty Murray of Washington about whether he advocated against the reductions internally, Kennedy defended the proposed cuts by referencing what he described as wasteful research at the National Institutes of Health, specifically mentioning studies related to gender-affirming hormone therapy and transgender and gender-diverse adult health.

The Secretary acknowledged that earlier cancellations of grants to the Substance Abuse and Mental Health Services Administration were incorrect, describing them as “a mistake…an overcorrection” that he reversed within 24 hours upon learning of the situation. This admission came amid broader scrutiny of HHS spending priorities under his leadership.

Kennedy’s testimony also addressed vaccine-related controversies, including his assertion that mRNA vaccines are ineffective for respiratory illnesses—a claim challenged by Senator Baldwin, who entered a New England Journal of Medicine study into the hearing record that contradicted his position. He maintained his support for certain vaccine initiatives, stating he authorized funding for cancer vaccines and a universal flu vaccine while defending the cancellation of $500 million in grants for vaccines he characterized as ineffective.

Further questioning from Senator Jeanne Shaheen of New Hampshire focused on delayed funding for GAVI, the global vaccine alliance. Kennedy acknowledged holding up the $300 million in congressionally approved funds due to concerns about GAVI’s relationship with the World Health Organization—from which the U.S. Withdrew under the Trump administration—and its use of older vaccine formulations. He ultimately agreed to appoint an HHS liaison to work with Shaheen’s office to resolve the funding delay, noting the stakes involved in protecting approximately 1.5 million children worldwide.

The ongoing debate over HHS funding levels occurs against a backdrop of Kennedy’s broader public health agenda, which includes promoting new dietary guidelines emphasizing whole foods through his Make America Health Again initiative. While these efforts have received some bipartisan recognition, his testimony continues to draw scrutiny from lawmakers concerned about the implications of reduced federal health spending on disease prevention, health equity, and access to essential medical services—factors that indirectly influence the health and availability of entertainment industry workers and audiences.

As the budget process moves forward, the entertainment sector remains attentive to how federal health policy decisions may affect workplace safety standards, healthcare access for production crews, and public health messaging that intersects with media content creation and distribution.